Maximum quantity allowed is 999
请选择数量
CAS RN: 30652-11-0 | 产品编码: H0944
3-Hydroxy-1,2-dimethyl-4(1H)-pyridone
×
![]()
×
技术规格
| Appearance | White to Almost white powder to crystal |
| Purity(GC) | min. 98.0 % |
| Purity(Nonaqueous Titration) | min. 98.0 % |
| Solubility in Acetic acid | almost transparency |
| NMR | confirm to structure |
物性（参考值）
| 熔点 | 260 °C(dec.) |
GHS
| 象形图 |
|
| 信号词 | Warning |
| 危险性说明 | H302 : Harmful if swallowed. H315 : Causes skin irritation. H319 : Causes serious eye irritation. |
| 防范说明 | P501 : Dispose of contents/ container to an approved waste disposal plant. P270 : Do not eat, drink or smoke when using this product. P264 : Wash skin thoroughly after handling. P280 : Wear protective gloves/ eye protection/ face protection. P302 + P352 : IF ON SKIN: Wash with plenty of water. P337 + P313 : If eye irritation persists: Get medical advice/ attention. P305 + P351 + P338 : IF IN EYES: Rinse cautiously with water for several minutes. Remove contact lenses, if present and easy to do. Continue rinsing. P362 + P364 : Take off contaminated clothing and wash it before reuse. P332 + P313 : If skin irritation occurs: Get medical advice/ attention. P301 + P312 + P330 : IF SWALLOWED: Call a POISON CENTER/doctor if you feel unwell. Rinse mouth. |
相关法规
| RTECS# | UU7785940 |
运输信息
| HS编码* | 2933.39-000 |
应用
Mitophagy research
References
- Loss of iron triggers PINK1/Parkin-independent mitophagy
- PINK1 is activated by mitochondrial membrane potential depolarization and stimulates Parkin E3 ligase activity by phosphorylating Serine 65
应用
Deferiprone: A Potent Chelating Agent with an Affinity for Ferric Ion [Fe (III)]
Deferiprone is a potent chelating agent with an affinity for ferric ion [Fe (III)]. Reportedly, deferiprone binds with ferric ions to form neutral 3:1 (deferiprone:iron) complexes that are stable over a wide range of pH values. And then, deferiprone has a lower binding affinity for other metals such as copper, aluminum and zinc than for iron. Deferiprone, an iron chelator that may cross the blood-brain barrier, is used therapeutically in conditions of transfusional iron overload and Friedreich's ataxia (FRDA) for the excretion of iron. (The product is for research purpose only.)
References
- Role of deferiprone in chelation therapy for transfusional iron overload (a review)
- Oral chelators Deferasirox and Deferiprone for transfusional iron overload in thalassemia major: new data, new questions
- Deferiprone for the treatment of Friedreich's ataxia
- Chromatography of 3-hydroxypyridin-4-ones: novel orally active iron chelators
- Development of a fast LC-MS/MS assay for the determination of deferiprone in human plasma and application to pharmacokinetics
参考文献
TCIMail
产品文档 (部分产品的分析图谱无法提供，敬请谅解。)
化学品安全说明书(SDS)
请选择语言。
如需更多帮助，请联系我 们。
技术规格
CoA及其他文档
请输入批号
批号输入有误。请输入中横线前的4-5个字母数字字符。
示例 CoA
可下载CoA示例。注：该示例不一定是最新批次的CoA。
目前没有该产品的 CoA 示例。
分析图谱
请输入批号
批号输入有误。请输入中横线前的4-5个字母数字字符。
很抱歉，您搜索的分析图谱无法提供。